Liver Diseases  >>  saxagliptin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
saxagliptin / Generic mfg.
NCT01086293: Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Completed
N/A
113505
US, Europe
AstraZeneca, Bristol-Myers Squibb, University of Pennsylvania
Diabetes Mellitus, Type 2
12/15
12/15

Download Options